The present invention is directed to the novel polymorphic Form F of Atorvastatin calcium, processes for the preparation thereof and pharmaceutical compositions comprising this crystalline form.
申请公布号
AU2003297594(A1)
申请公布日期
2004.06.23
申请号
AU20030297594
申请日期
2003.11.26
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.
发明人
FRITZ BLATTER;MARTIN SZELAGIEWICZ;PAUL ADRIAAN VAN DER SCHAAF